366 results
The most recent COVID variant, Omicron, was identified in November 2021 and rapidly spread across the globe. Here are answers to the top five questions about the Omicron variant.
Nonfatal myocardial infarction (MI) is a commonly used surrogate outcome in trials of interventions for acute coronary syndromes. The EBM Focus team evaluates whether it is a reasonable endpoint.
DynaMed editors dig into the now published EMERGE and ENGAGE trials of aducanumab for Alzheimer disease in this latest EBM Focus.
Read about a large trial evaluating the initiation of antihypertensive therapy at lower blood pressure targets during pregnancy in the latest EBM Focus.
Surgery is generally associated with cardiovascular risk, but is eye surgery a risk for acute myocardial infarction? Read the latest EBM Focus article to find out.
A new study estimates that one in seven persons diagnosed with breast cancer through screening will be unnecessarily treated due to overdiagnosis. Read more about this study in this EBM Focus article.
With a current outbreak of Japanese encephalitis virus (JEV) occurring in Australia, read about the discovery of mosquitoes as disease vectors from the Infectious Disease team at DynaMed.
How does a revised newborn pulse-ox screening algorithm for critical congenital heart defects (CCHD) compare to standard screening? The EBM Focus team at DynaMed® investigates.
Read about a large, real-time public health study evaluating effectiveness of a third (booster) dose of Pfizer COVID-19 vaccine from the EBM Focus team at DynaMed®.
Low levels of vitamin D have been associated with a variety of poor health outcomes, but do vitamin D supplements work? Read this EBM Focus article to find out more.